Keurig Dr Pepper Inc. Earnings Per Share Disclosure
| For the Year Ended December 31, | |||||||||||||||||
| (in millions, except per share data) | 2025 | 2024 | 2023 | ||||||||||||||
| Net income | $ | 2,079 | $ | 1,441 | $ | 2,181 | |||||||||||
| Weighted average common shares outstanding | 1,358.1 | 1,362.2 | 1,399.3 | ||||||||||||||
| Dilutive effect of stock-based awards | 4.7 | 6.1 | 9.1 | ||||||||||||||
| Weighted average common shares outstanding and common stock equivalents | 1,362.8 | 1,368.3 | 1,408.4 | ||||||||||||||
| Basic EPS | $ | 1.53 | $ | 1.06 | $ | 1.56 | |||||||||||
| Diluted EPS | 1.53 | 1.05 | 1.55 | ||||||||||||||
| Anti-dilutive shares excluded from the diluted weighted average shares outstanding calculation | 1.3 | 0.8 | 1.0 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 24, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 22, 2024 | |
| 2022 | Feb 23, 2023 | |
| 2021 | Feb 24, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Feb 27, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Feb 14, 2018 | |
| 2016 | Feb 14, 2017 | |
| 2015 | Feb 23, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.